Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Intrathecal Gene Delivery Clinical Trial of scAAV9.P546.SLC6A1 for SLC6A1 Neurodevelopmental Disorder

NCT07173153 is registered in ClinicalTrials.gov with Emily de los Reyes as lead sponsor.

NCT NCT07173153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07173153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Intrathecal Gene Delivery Clinical Trial of scAAV9.P546.SLC6A1 for SLC6A1 Neurodevelopmental Disorder
Lead sponsor
Emily de los Reyes
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
August 25, 2025
Completion date
August 25, 2030
Enrollment
1 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

slc6a1